Back to Search
EVELYNE SCHUETZ, MD
MD
Obstetrics & Gynecology Physician
NPI: 1700884012IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
R5H93(MO)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Class of 1984
Research & Publications (20)
Microglia-targeted pharmacotherapy in retinal neurodegenerative diseases.
PMID 15473251·Curr Drug Targets·2004
6-review
Neuro-glial interactions in the adult rat retina after reaxotomy of ganglion cells: examination of neuron survival and phagocytic microglia using fluorescent tracers.
PMID 15168904·Brain Res Bull·2004
7-preclinical
Regeneration of ganglion cell axons into a peripheral nerve graft alters retinal expression of glial markers and decreases vulnerability to re-axotomy.
PMID 12808198·Restor Neurol Neurosci·2003
4-observational
[Neural transplantation for restoration of nerve function. Physiological basis and clinical results].
PMID 14652923·Med Monatsschr Pharm·2003
6-review
Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans.
PMID 18825162·Pharmacogenomics J·2009
8-other
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.
PMID 19349540·J Clin Oncol·2009
8-other
The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulation.
PMID 19251824·Drug Metab Dispos·2009
8-other
Pharmacogenetic pathway analysis of docetaxel elimination.
PMID 18509327·Clin Pharmacol Ther·2009
4-observational
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.
PMID 19633067·Mol Pharmacol·2009
4-observational
A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor.
PMID 19171678·Drug Metab Dispos·2009
8-other
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
PMID 18309947·J Clin Oncol·2008
4-observational
Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.
PMID 18180275·Drug Metab Dispos·2008
4-observational
The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation.
PMID 17954524·Drug Metab Dispos·2008
7-preclinical
Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression.
PMID 17925385·Drug Metab Dispos·2008
8-other
The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans.
PMID 18490434·Drug Metab Dispos·2008
8-other
Transporter-mediated protection against thiopurine-induced hematopoietic toxicity.
PMID 18593894·Cancer Res·2008
7-preclinical
Mapping the genetic architecture of gene expression in human liver.
PMID 18462017·PLoS Biol·2008
7-preclinical
Influence of solute carriers on the pharmacokinetics of CYP3A4 probes.
PMID 18509328·Clin Pharmacol Ther·2008
4-observational
A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine.
PMID 18505790·Drug Metab Dispos·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1101 HIGHWAY K
O FALLON, MO 63366 - Phone
- (636) 379-6363
Quick Facts
- NPI
- 1700884012
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile